📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Natural Capsules Subsidiary Signs ₹60 Cr Strategic CDMO Agreement with Fermbox Bio
Natural Biogenex, a material subsidiary of Natural Capsules Limited, has entered into a strategic framework agreement with Fermbox Bio to bolster fermentation-based CDMO capabilities. As part of the deal, Fermbox will provide equipment worth up to ₹60 crore at NBPL's Tumkur facility. This collaboration enables the company to target global biopharma and industrial biotech clients using advanced fermentation technology. The partnership is strategically timed to benefit from India's BioE3 Policy and the growing global demand for outsourced biomanufacturing.
Key Highlights
Natural Biogenex (NBPL) signs definitive agreements with Fermbox Bio for fermentation-based CDMO services.
Fermbox Bio to provide advanced equipment placement and technology worth up to ₹60 crore at NBPL’s Tumkur plant.
NBPL will handle GMP-compliant manufacturing, quality assurance, and regulatory compliance for the partnership.
The collaboration targets high-value segments in both pharmaceutical and industrial biotechnology.
The move aligns with the Indian government's BioE3 Policy to accelerate biomanufacturing innovation.
💼 Action for Investors
Investors should view this as a significant value-accretive step into high-margin CDMO services. Monitor the operationalization of the ₹60 crore equipment and the subsequent impact on the subsidiary's order book and margins.
Natural Capsules Subsidiary NBPL Signs Mfg Deal; Fermbox to Invest ₹60 Crore
Natural Biogenex Private Limited (NBPL), a material subsidiary of Natural Capsules Limited, has entered into a Framework and Contract Manufacturing agreement with Fermbox Bio Private Limited. Under this agreement, Fermbox will utilize the spare fermentation capacity of NBPL's plant. Significantly, Fermbox will invest up to ₹60 Crores in plant and machinery that will be owned by them but housed within NBPL's factory. This strategic move allows the company to monetize idle assets and leverage external capital for equipment, likely enhancing the subsidiary's operational throughput and revenue.
Key Highlights
Material subsidiary NBPL enters into a Framework & Contract Manufacturing agreement with Fermbox Bio.
Fermbox to invest up to ₹60 Crores in specialized plant and machinery at NBPL's facility.
The agreement aims to utilize the existing spare capacity of NBPL's fermentation plant.
Investment in machinery is funded by Fermbox while being integrated into NBPL's operational site.
The transaction is conducted at arm's length and does not involve related party interests.
💼 Action for Investors
Investors should monitor the execution timeline of the ₹60 Crore machinery installation and the resulting revenue growth in the subsidiary. This development is a positive indicator of better asset utilization and strategic partnership capabilities.
Kapston Services Allots 1.01 Crore Bonus Equity Shares in 1:2 Ratio
Kapston Services Limited has completed the allotment of 1,01,44,061 bonus equity shares to eligible shareholders as of the record date, March 06, 2026. The bonus issue was carried out in a 1:2 ratio, providing one new share for every two existing shares held. This corporate action has increased the company's total paid-up equity share capital from Rs. 10.14 crore to Rs. 15.21 crore. The newly allotted shares rank pari-passu with existing shares and will increase the overall liquidity of the stock.
Key Highlights
Allotment of 1,01,44,061 bonus equity shares with a face value of Rs. 5 each
Bonus ratio of 1:2 implemented for shareholders as of the March 06, 2026 record date
Total number of equity shares increased from 2,02,88,122 to 3,04,32,183
Paid-up equity share capital expanded from Rs. 10,14,40,610 to Rs. 15,21,60,915
New shares carry the same rights and rank pari-passu with existing equity shares
💼 Action for Investors
Investors should account for the increased share count in their portfolios and note that the stock price has been adjusted to reflect the 1:2 bonus ratio. No further action is required as the allotment process is now complete.
Kapston Services Sets March 6, 2026, as Record Date for 1:2 Bonus Issue
Kapston Services Limited has officially fixed Friday, March 06, 2026, as the record date for its upcoming bonus share issuance. The company will issue bonus shares in a 1:2 ratio, meaning shareholders will receive one new fully paid-up equity share for every two shares held. Each share has a face value of Rs. 5. This corporate action is intended to reward existing shareholders and improve the liquidity of the stock in the market.
Key Highlights
Record date for bonus share eligibility is fixed as March 06, 2026
Bonus ratio confirmed at 1:2 (one new share for every two existing shares)
Face value of the equity shares remains constant at Rs. 5 per share
The issuance is being conducted under Regulation 42 of SEBI Listing Regulations
💼 Action for Investors
Investors seeking to benefit from the bonus issue must ensure they hold the shares in their demat account before the ex-date. Note that while the share count increases, the stock price will adjust downward proportionally on the ex-date.
Kapston Services Shareholders Unanimously Approve Bonus Issue and Capital Increase
Kapston Services Limited has received shareholder approval for two major resolutions via postal ballot: an increase in authorized share capital and the issuance of bonus shares. Both resolutions were passed with 100% of the 1,66,18,621 polled votes in favor, representing 81.91% of the total outstanding shares. The promoter group participated fully with 1,47,83,390 shares, while public participation was approximately 33.34% of their holding. This approval allows the company to proceed with its planned capitalization of reserves through the bonus issue.
Key Highlights
100% of the 1.66 crore votes polled were in favor of the bonus share issuance.
The resolution to increase authorized share capital was passed with a requisite majority.
Overall shareholder participation in the postal ballot was 81.91% of the total 2.02 crore shares.
Promoter group participation was 100% (1.47 crore shares), while public non-institutional participation was 33.34%.
💼 Action for Investors
Investors should monitor the company's upcoming announcements for the 'Record Date' to determine eligibility for the bonus shares.
Natural Capsules Seeks Approval to Increase Investment and Loan Limits to ₹250 Crore
Natural Capsules Limited has issued a postal ballot notice to seek shareholder approval for increasing the limits of investments, loans, and guarantees under Section 186 of the Companies Act. The company is proposing a new aggregate limit of ₹250 Crore, which would allow the Board greater flexibility in capital deployment and inter-corporate financial support. The approval is being sought through a special resolution via electronic voting. This move suggests the company may be preparing for future expansions, acquisitions, or strategic investments.
Key Highlights
Proposed enhancement of limits for loans, investments, and guarantees to a maximum of ₹250 Crore.
Approval sought via Special Resolution through a Postal Ballot process conducted electronically.
E-voting period is scheduled from February 26, 2026, to March 27, 2026.
The cut-off date for determining shareholder eligibility for voting was February 20, 2026.
💼 Action for Investors
Investors should monitor the outcome of the vote and subsequent announcements to see how the company intends to utilize this significantly higher limit of ₹250 Crore. While it provides operational flexibility, the specific deployment of these funds will determine the long-term impact on shareholder value.
IIFL Capital Q3 FY26: Operational PBT Drops 36% YoY to ₹119 Cr Amid Rising Costs
IIFL Capital Services reported flat consolidated operational revenues of ₹586 crores for Q3 FY26, showing stagnation on both a QoQ and YoY basis. Operational PBT saw a sharp decline of 36% YoY to ₹119 crores, primarily driven by a 17% increase in employee costs and higher administrative expenses. The bottom line was supported by a one-time gain of ₹90 crores from the sale of real estate and mark-to-market gains on BSE shares. Additionally, the company paid ₹27 crores in ad hoc taxes following an Income Tax Department search, which remains an ongoing assessment process.
Key Highlights
Consolidated operational revenue remained flat at ₹586 crores for Q3 FY26.
Operational PBT fell 36% YoY to ₹119 crores due to rising employee costs (₹175 crores) and admin expenses (₹91 crores).
Financial Product Distribution (FPD) income grew 25% YoY to ₹134 crores, showing strong traction.
Other income included a significant ₹90 crore gain from real estate asset sales and BSE share MTM.
Average Daily Turnover (ADTO) increased 19% QoQ to ₹3,14,660 crores, driven by F&O volumes.
💼 Action for Investors
Investors should be cautious of the declining operational margins and the ongoing tax assessment proceedings. While the growth in distribution income and the pivot toward wealth management are positive, the rising cost-to-income ratio needs to be monitored closely.
Natural Capsules Q3 FY26: Revenue drops 14% Y-o-Y to ₹37.75 Cr; Net Loss at ₹7.12 Cr
Natural Capsules reported a weak Q3 FY26 with consolidated revenue declining 14% Y-o-Y to ₹37.75 Cr, primarily due to a temporary regulatory shutdown of its Puducherry unit. The company posted a net loss of ₹7.12 Cr compared to a marginal profit in the previous year, as EBITDA margins crashed to -6.16% from 9.73% Y-o-Y. While the Puducherry plant has resumed operations and US tariffs on HPMC capsules have eased, the API fermentation block continues to face commercial scale-up challenges. Management is now exploring contractual partnerships to improve asset utilization and expects a recovery in Q4 FY26.
Key Highlights
Consolidated Revenue fell 14% Y-o-Y to ₹37.75 Cr due to regulatory issues and deferred dispatches at the Puducherry facility.
EBITDA turned negative at -₹2.33 Cr, with margins contracting by 1,589 bps Y-o-Y to -6.16%.
Net Loss for the quarter stood at ₹7.12 Cr, bringing the 9M FY26 total loss to ₹19.69 Cr.
US trade tariffs on HPMC capsules have been eased, restoring growth visibility in the North American market.
Company is in advanced talks with partners for contract manufacturing at its fermentation block to mitigate technical scale-up delays.
💼 Action for Investors
Investors should maintain a cautious stance given the significant bottom-line erosion and execution hurdles in the API segment. Monitor Q4 results closely to verify management's guidance on operational recovery and the finalization of fermentation block partnerships.
Natural Capsules Q3 Net Profit Crashes 79% YoY to ₹36 Lakhs; Allots 45,000 ESOP Shares
Natural Capsules reported a significant decline in financial performance for the quarter ended December 31, 2025. Standalone revenue fell 21% YoY to ₹34.15 crore, while net profit plummeted 79% YoY to just ₹0.36 crore. On a consolidated basis, the company barely broke even with a net profit of ₹0.10 crore. The board also approved the allotment of 45,000 equity shares under its ESOP scheme and is seeking to increase its investment limits via postal ballot.
Key Highlights
Standalone Net Profit declined sharply to ₹36.23 Lakhs from ₹170.32 Lakhs in the previous year's quarter.
Revenue from operations decreased to ₹3,414.64 Lakhs compared to ₹4,341.18 Lakhs YoY.
Consolidated Net Profit for Q3 FY26 stood at a marginal ₹10.33 Lakhs, down from ₹250.78 Lakhs in Q2 FY26.
Paid-up share capital increased to ₹10.38 Crore following the allotment of 45,000 ESOP shares at ₹10 each.
Board approved a postal ballot to enhance limits for loans and investments under Section 186 of the Companies Act.
💼 Action for Investors
The results show a severe deterioration in profitability and margins that warrants immediate caution. Investors should wait for management commentary to understand if these headwinds are transitory or structural before considering any new positions.
Natural Capsules Allots 45,000 ESOP Shares; Q3 Net Profit Drops to Rs 36.23 Lakhs
Natural Capsules Limited has allotted 45,000 equity shares following the exercise of options under its ESOP 2025 plan, increasing the paid-up capital to Rs 10.39 crore. However, the company's standalone financial results for Q3 FY25 show a significant downturn, with net profit plunging to Rs 36.23 lakhs from Rs 170.32 lakhs in the same quarter last year. Revenue from operations also declined to Rs 3,414.64 lakhs compared to Rs 4,341.18 lakhs YoY. Additionally, the board has approved a postal ballot to enhance limits for inter-corporate loans and investments under Section 186.
Key Highlights
Allotment of 45,000 equity shares at an exercise price of Rs 10 per share under ESOP 2025.
Standalone Net Profit for Q3 FY25 fell sharply to Rs 36.23 lakhs from Rs 170.32 lakhs YoY.
Revenue from operations decreased by approximately 21% YoY to Rs 3,414.64 lakhs.
Total paid-up share capital increased from Rs 10,34,11,540 to Rs 10,38,61,540.
Board approved seeking shareholder approval to enhance investment and loan limits under Section 186.
💼 Action for Investors
Investors should exercise caution as the company reports a substantial decline in both top-line and bottom-line performance for the December quarter. Monitor management's commentary on margin pressures and the strategic intent behind increasing investment limits.
Natural Capsules Q3 Net Profit Plummets 79% YoY to ₹36.23 Lakhs; Allots 45,000 ESOP Shares
Natural Capsules Limited reported a significantly weak performance for Q3 FY25, with revenue from operations dropping 21.3% YoY to ₹34.15 crore. Net profit witnessed a sharp decline of 78.7% YoY, falling to ₹36.23 lakhs from ₹1.70 crore in the year-ago period. On a sequential basis, profits fell nearly 87% from ₹2.81 crore in Q2 FY25. The company also approved the allotment of 45,000 equity shares under its ESOP scheme and is seeking shareholder approval to increase investment and loan limits.
Key Highlights
Revenue from operations declined to ₹3,414.64 lakhs in Q3 FY25 from ₹4,341.18 lakhs in Q3 FY24.
Net profit for the quarter stood at ₹36.23 lakhs, a massive drop from ₹281.04 lakhs in the preceding quarter.
Basic EPS fell sharply to ₹0.35 from ₹2.72 in Q2 FY25 and ₹1.65 in Q3 FY24.
Allotted 45,000 equity shares of ₹10 face value at an exercise price of ₹10 per share under ESOP 2025.
Board approved a Postal Ballot to enhance limits for loans, guarantees, and investments under Section 186 of the Companies Act.
💼 Action for Investors
Investors should exercise caution as the company shows significant margin compression and declining top-line growth. It is essential to monitor management's explanation for the profit slump and the intended use of the expanded investment limits.
Natural Capsules Q3 Net Profit Plummets 78% YoY to ₹36.23 Lakhs; Revenue Down 21%
Natural Capsules Limited reported a significant decline in financial performance for the quarter ended December 31, 2025. Standalone revenue from operations fell 21.3% YoY to ₹34.15 crore, while net profit saw a sharp 78.7% YoY drop to ₹0.36 crore. On a sequential basis, the profit decline was even steeper, falling 87% from ₹2.81 crore in Q2 FY26. The board also approved the allotment of 45,000 ESOP shares and is seeking to enhance investment limits under Section 186 of the Companies Act.
Key Highlights
Standalone Revenue from operations declined 21.3% YoY to ₹3,414.64 Lakhs from ₹4,341.18 Lakhs.
Net Profit crashed 78.7% YoY to ₹36.23 Lakhs compared to ₹170.32 Lakhs in the previous year's quarter.
Total expenses for the quarter stood at ₹3,579.48 Lakhs, leading to a significant compression in margins.
Allotted 45,000 equity shares of ₹10 each under the ESOP 2025 plan, increasing paid-up capital to ₹10.38 crore.
Board approved a Postal Ballot to increase limits for loans and investments under Section 186 of the Companies Act.
💼 Action for Investors
Investors should exercise caution as the company shows severe margin pressure and a sharp decline in both top and bottom lines. It is critical to wait for management commentary regarding the operational challenges that led to this significant quarterly underperformance.
Kapston Services Q3 FY26 Net Profit Surges 64% YoY to ₹7.43 Cr; MD Re-appointed
Kapston Services reported a strong performance for the quarter ended December 31, 2025, with consolidated revenue growing 16.5% YoY to ₹212.65 crore. Net profit saw a significant jump of 64% YoY, reaching ₹7.43 crore compared to ₹4.53 crore in the same period last year. The company's 9-month PAT of ₹20.61 crore has already surpassed the total PAT for the entire previous fiscal year (FY25). Additionally, the board has re-appointed Srikanth Kodali as Managing Director and reaffirmed a previously recommended 1:2 bonus issue.
Key Highlights
Consolidated Revenue from Operations grew 16.5% YoY to ₹212.65 crore in Q3 FY26.
Net Profit after Tax (PAT) increased by 64% YoY to ₹7.43 crore from ₹4.53 crore.
9M FY26 PAT stands at ₹20.61 crore, exceeding the full FY25 PAT of ₹17.84 crore.
Basic EPS for the quarter improved to ₹3.66 from ₹2.23 in the corresponding previous year quarter.
Board approved the re-appointment of Mr. Srikanth Kodali as Managing Director with revised remuneration.
💼 Action for Investors
The company is showing strong operational leverage with profit growth significantly outstripping revenue growth. Investors should stay positive given the robust 9-month performance and the upcoming 1:2 bonus issue.
Kapston Services Q3 FY26 Net Profit Jumps 64% YoY to ₹7.43 Cr; MD Re-appointed
Kapston Services reported a strong financial performance for the quarter ended December 31, 2025, with consolidated revenue rising 16.1% YoY to ₹212.06 crore. Net profit for the quarter surged by 64% YoY to ₹7.43 crore, up from ₹4.53 crore in the previous year. The nine-month performance was even stronger, with net profit growing 75% to ₹20.61 crore. The board also approved the re-appointment of Srikanth Kodali as Managing Director and noted a previously recommended 1:2 bonus issue.
Key Highlights
Consolidated Revenue from Operations increased 16.1% YoY to ₹212.06 crore.
Net Profit after tax surged 64% YoY to ₹7.43 crore for Q3 FY26.
9M FY26 Net Profit reached ₹20.61 crore, representing a 75% growth over 9M FY25.
Basic EPS for the quarter improved to ₹3.66 from ₹2.23 in the year-ago period.
Board re-appointed Srikanth Kodali as Managing Director with revised remuneration.
💼 Action for Investors
The company demonstrates robust growth momentum and operational efficiency, making it a positive watch for small-cap investors. Investors should track the upcoming 1:2 bonus issue and shareholder approval for the MD's re-appointment.
IIFL Capital Q3 PAT Surges 121% Q-o-Q to ₹188 Cr; Declares ₹3 Interim Dividend
IIFL Capital Services reported flat operating revenue of ₹586 crore for Q3FY26, while operating profit before tax fell 27% Q-o-Q to ₹119 crore due to increased employee costs for wealth management expansion. Despite the operating dip, Profit After Tax (PAT) jumped 121% sequentially to ₹188 crore, supported by non-operating income. The company's distribution AUM grew 9% Q-o-Q to ₹48,322 crore, and the board declared an interim dividend of ₹3 per share. The investment banking division remained active, completing 12 deals during the quarter.
Key Highlights
Consolidated Operating Revenue stood at ₹586 crore, flat Q-o-Q and up 1% Y-o-Y.
Operating Profit Before Tax declined 27% Q-o-Q to ₹119 crore, impacted by wealth management hiring.
Profit After Tax (PAT) rose 121% Q-o-Q to ₹188 crore, though it declined 5% on a Y-o-Y basis.
Distribution AUM reached ₹48,322 crore, while Custody AUM stood at ₹2,12,314 crore.
Interim dividend of ₹3 per share declared with a record date of February 16, 2026.
💼 Action for Investors
Investors should note the divergence between declining operating profits and rising net profit, which suggests reliance on non-core income this quarter. Monitor if the aggressive investment in wealth management personnel translates into higher revenue growth in the coming quarters.
IIFL Capital Q3 FY26 PAT at ₹1,873 Mn; Distribution AUM Surges 54% YoY
IIFL Capital Services reported a flat Q3 FY26 revenue of ₹5,856 Mn, while PAT stood at ₹1,873 Mn, significantly aided by a ₹897 Mn one-time gain from property sales. The company's distribution assets grew robustly by 54% YoY to ₹483 Bn, and the Margin Trading Facility (MTF) book rose 59% YoY to ₹16.4 Bn. Despite a 17% YoY drop in 9M retail equities revenue, the investment banking segment remains a leader, completing 12 transactions in Q3 alone. The results reflect a strategic shift towards a diversified wealth management and distribution-led model.
Key Highlights
Distribution AUM surged 54% YoY to ₹483 Bn, with financial product distribution income up 28% for 9M FY26.
Net Margin Trading Facility (MTF) book expanded by 59% YoY to reach ₹16.4 Bn.
Investment Banking division completed 12 transactions in Q3 FY26 and maintained #1 rank in IPOs for CY2025.
Q3 PAT of ₹1,873 Mn includes a significant one-time gain of ₹897 Mn from the sale of property.
Retail equities revenue for 9M FY26 declined by 17% YoY to ₹8,231 Mn, reflecting pressure in the core broking segment.
💼 Action for Investors
Investors should monitor the company's ability to sustain growth in high-margin distribution and investment banking segments to offset the slowdown in retail broking. While the one-time property gain boosted the bottom line, the core operating profit decline suggests a need for cautious observation of margin trends.
IIFL Capital Services Declares Interim Dividend of Rs 3 Per Share (150%)
IIFL Capital Services Limited has announced an interim dividend of Rs. 3 per equity share for the financial year 2025-26. This payout represents 150% of the face value of Rs. 2 per share. The company has fixed February 16, 2026, as the record date to determine shareholder eligibility. Eligible investors can expect the dividend payment to be processed on or before March 11, 2026.
Key Highlights
Interim dividend of Rs. 3 per equity share declared for FY 2025-26
Dividend payout is 150% based on a face value of Rs. 2 per share
Record date for eligibility set as Monday, February 16, 2026
Payment to be completed or dispatched by March 11, 2026
💼 Action for Investors
Investors interested in the dividend should ensure they hold the stock before the ex-dividend date. The 150% payout indicates a strong commitment to returning capital to shareholders.
IIFL Capital Services Declares Rs 3 Interim Dividend; Sets Record Date for Feb 16
IIFL Capital Services Limited (formerly IIFL Securities) has announced an interim dividend of Rs. 3 per equity share for the financial year 2025-2026. This payout represents 150% of the face value of Rs. 2 per share. The company has established February 16, 2026, as the record date to identify eligible shareholders. The dividend distribution is expected to be completed on or before March 11, 2026.
Key Highlights
Interim dividend of Rs. 3 per equity share declared for FY 2025-26
Dividend payout represents 150% of the face value of Rs. 2 per share
Record date for shareholder eligibility is fixed as February 16, 2026
Payment or dispatch of dividend to be completed by March 11, 2026
💼 Action for Investors
Investors seeking dividend income should ensure they hold the stock before the ex-dividend date to qualify for the Rs. 3 per share payout. This announcement reflects the company's commitment to returning capital to shareholders.
IIFL Capital Services Declares Rs 3 Interim Dividend; Sets Feb 16 as Record Date
IIFL Capital Services Limited has announced an interim dividend of Rs 3 per equity share for the financial year 2025-26, which translates to a 150% payout on the face value of Rs 2. The Board of Directors approved this payout in their meeting held on February 10, 2026. Shareholders must be on the company's records by February 16, 2026, to be eligible for the payment. The company expects to complete the dividend distribution by March 11, 2026.
Key Highlights
Interim dividend of Rs 3 per equity share declared for FY 2025-26
Dividend payout represents 150% of the face value of Rs 2 per share
Record date for eligibility fixed as Monday, February 16, 2026
Payment or dispatch of dividend to be completed on or before March 11, 2026
💼 Action for Investors
Investors interested in the dividend should ensure they own the stock before the ex-dividend date to qualify for the Rs 3 per share payout. This move reflects the company's healthy cash position and commitment to returning value to shareholders.
IIFL Capital Services Declares Rs 3 Interim Dividend; Sets Feb 16 as Record Date
IIFL Capital Services Limited has announced an interim dividend of Rs 3 per equity share for the financial year 2025-26, which translates to 150% of its face value of Rs 2. The Board of Directors approved this payout in their meeting held on February 10, 2026. Shareholders must be on the company's records by February 16, 2026, to be eligible for the payout. The dividend is scheduled to be paid or dispatched to eligible investors on or before March 11, 2026.
Key Highlights
Interim dividend of Rs 3 per equity share declared for FY 2025-26
Dividend payout represents 150% of the face value of Rs 2 per share
Record date for eligibility fixed as Monday, February 16, 2026
Payment or dispatch of dividend to be completed by March 11, 2026
💼 Action for Investors
Investors seeking dividend income should ensure they hold the stock before the ex-dividend date to qualify for the Rs 3 per share payout. The announcement reflects a healthy cash return to shareholders.